Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Gilenya manufacturer?

See the DrugPatentWatch profile for Gilenya

Who makes Gilenya (fingolimod)?

Gilenya (fingolimod) is manufactured and marketed by Novartis.

Does the “manufacturer” change by country or formulation?

The active ingredient is the same (fingolimod), but the marketed product holder can vary by country due to local licensing and distribution arrangements. In most markets, Novartis is the company associated with the product.

What’s the generic name and what does that mean for manufacturing?

Gilenya’s generic name is fingolimod. That matters because different companies may manufacture generic fingolimod products if/when biosimilar or generic alternatives are approved and marketed in a specific region, even though the original brand is tied to Novartis.

Related patent and manufacturer tracking

For manufacturer and patent/exclusivity details tied to fingolimod (brand and generic competition landscape), DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/



Other Questions About Gilenya :

Is gilenya safe for patients with eye disease? What is gilenya for? Are there eye problems associated with gilenya? Does gilenya cause a slow heart rate after the first dose? Does gilenya cause vision problems? How does gilenya treat multiple sclerosis? Does gilenya affect heart rate after the first dose?